Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºÒÀÓȯÀÚ¿¡ ÀÖ¾î °ú¹è¶õÀ¯µµÈÄ Àڱð­³» Àΰø¼öÁ¤¼ú½Ã ÀÓ½ÅÀ² Pregnancy Rate Following, Superovulation with Intrauterine Insemination in Infertile Patients

´ëÇÑ»êºÎÀΰúÇÐȸÁö 1999³â 42±Ç 12È£ p.2787 ~ 2791
ÃÖ¿µ¹Î, ÀÌÁö¿µ, ±¸½Â¿±, ¼­Ã¢¼®, ±è¼®Çö, ±èÁ¤±¸, ¹®½Å¿ë,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ¿µ¹Î (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç & ÀÇÇבּ¸¿ø Àα¸ÀÇÇבּ¸¼Ò

ÀÌÁö¿µ (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±¸½Â¿± (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
¼­Ã¢¼® (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç & ÀÇÇבּ¸¿ø Àα¸ÀÇÇבּ¸¼Ò
±è¼®Çö (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç & ÀÇÇבּ¸¿ø Àα¸ÀÇÇבּ¸¼Ò
±èÁ¤±¸ (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
¹®½Å¿ë (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç & ÀÇÇבּ¸¿ø Àα¸ÀÇÇבּ¸¼Ò

Abstract

¸ñÀû: º» ¿¬±¸¿¡¼­´Â °¡ÀÓ·Â ÀúÇÏÀÎ ºÒÀÓȯÀÚ¿¡¼­ °ú¹è¶õÀ¯µµÈÄ Àڱð­³» Àΰø¼öÁ¤¼úÈÄ ÀÓ½ÅÀ²À» ÆľÇÇÏ°íÀÚ ÇÏ¿´´Ù.
¿¬±¸¹æ¹ý: 1993³â 3¿ùºÎÅÍ 1999³â 3¿ù±îÁö 48¸íÀÇ ´ë»óȯÀÚ¿¡¼­ ÃÑ 72ÁÖ±âÀÇ °ú¹è¶õÀ¯µµÈÄ Àڱð­³» Àΰø¼öÁ¤¼úÀ» ½ÃÇàÇÏ¿´´Ù. ¿ù°æÁÖ±â Á¦ 3ÀÏ°ºÎÅÍ ¼º¼±ÀÚ±ØÈ£¸£¸óÀ» ÀÌ¿ëÇÑ °ú¹è¶õÀ¯µµ¸¦ ½ÃÀÛÇÏ¿´À¸¸ç, 15Áֱ⿡¼­´Â °ú¹è¶õ À¯µµ½Ã GnRH agonist »ç¿ëÀ» º´ÇÕÇÏ¿´´Ù.
°á°ú: ½Ã¼úÁÖ±â´ç ÀÓ½ÅÀ²Àº 33.3% (24/72)¿´°í ½Ã¼úȯÀÚ´ç ÀÓ½ÅÀ²Àº 45.8% (22/48)¿´´Ù. ºÒÀÓÀÇ ¿øÀÎÀ¸·Î´Â ¹è¶õÀå¾Ö 19¸í, ¿øÀκҸíÀÇ ºÒÀÓ 19¸í, Àڱ󻸷Áõ 8¸í µîÀ̾ú´Ù. ºÒÀÓ¿øÀκ° ÁÖ±â´ç ÀÓ½ÅÀ²Àº ¹è¶õÀå¾ÖÀÎ °æ¿ì 43.9% (17/41), ¿øÀκҸíÀÇ ºÒÀÓÀÎ °æ¿ì 31.6% (6/19), Àڱ󻸷ÁõÀÇ °æ¿ì 10% (1/10)·Î¼­ Àڱ󻸷Áõ È­ÀÚ¿¡¼­ °¡Àå ³·Àº ÀÓ½ÅÀ²À» º¸¿´´Ù. °ú¹è¶õÀ¯µµ½Ã GnRH agonist¸¦ »ç¿ëÇÑ È¯ÀÚ±ºÀÇ ÀÓ½ÅÀ²Àº 40.0% (6/15)·Î »ç¿ëÇÏÁö ¾ÊÀº ±ºÀÇ 31.6% (18/57)¿¡ ºñÇØ ³ô¾ÒÀ¸³ª Åë°èÇÐÀû À¯ÀǼºÀº ¾ø¾úÀ¸¸ç, hCG Åõ¿©ÀÏ¿¡ ½ÃÇàÇÑ Áú½Ä ÃÊÀ½ÆÄ»ó 16 §®ÀÌ»óÀÎ ³­Æ÷¼ö°¡ 1°³ÀÏ ¶§ ÁÖ±â´ç ÀÓ½ÅÀ²Àº 9.1%, 2°³ÀÏ ¶§ 41.7%, 3°³ÀÏ ¶§ 42.9%, 4°³ ÀÌ»óÀÏ ¶§ 46.2%·Î¼­ ³­Æ÷¼ö¿¡ µû¶ó ÀÓ½ÅÀ²ÀÌ Áõ°¡ÇÏ°í ÀÖÀ¸³ª, 2°³ ÀÌ»óÀÏ °æ¿ì Å« Â÷ÀÌ°¡ ¾ø¾ú´Ù. »ýÁ¸Ç¥ ºÐ¼® (life table analysis)À¸·Î ¾ò¾îÁø ´©Àû ÀÓ½ÅÀ²Àº 1Áֱ⠽ÃÇàÈÄ 25.0%, 2ÁÖ±âÈÄ 46.9%, 3ÁÖ±âÈÄ 61.1%, 4ÁÖ±â ÀÌ»óÈÄ 74.1%¿´´Ù.
°á·Ð: °ú¹è¶õÀ¯µµÈÄ Àڱð­³» Àΰø¼öÁ¤¼úÀº °¡ÀÓ·Â ÀúÇÏÀÎ ºÒÀÓȯÀÚ¿¡¼­ ü¿Ü¼öÁ¤½Ã¼ú ½Ãµµ ÀÌÀü¿¡ À¯¿ëÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ ºÒÀÓÄ¡·á¹ýÀ¸·Î ÆǴܵȴÙ.
Objectives: To investigate the efficiency of superovulation with intrauterine insemination GUI) in infertile patients.
Materials and methods: Seventy-two cycles of superovulation with JUT in 48 infertile couples in which gonadotrophins were used for hyperstimulation were analysed retrospectively.
Results: Overall clinical pregnancy rate was 33.3% per cycle and 45.8% per patient. By the infertility factor, patients with endometriosis showed the lowest pregnancy rate (10%). Cumulative pregnancy rate (CPR), obtained by life-table analysis, increased as the number of cycles increased: 25.0% for one cycle, 33.3% for two cycle, 40% for three cycle and 50% for more than four cycle.
Conclusions: Superovulation with 1UI is an effective treatment modality in patients with subfecundity, and is worth while trying prior to in vitro fertilization procedure in those patients.

Å°¿öµå

°ú¹è¶õÀ¯µµ;Àڱð­³»Àΰø¼öÁ¤;ºÒÀÓ;°¡ÀÓ·ÂÀúÇÏ;Superovulation;Controlled ovarian hyperstimulation (COH);Intrauterine insemination (IUI);Infertility;Subfecundity

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS